1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. HALOZYME THERAPEUTICS INC.
Halozyme Therapeutics Inc. XNAS: HALO

Halozyme Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary ...

Read More
73.15 0.34 (0.47%)
New 52W High in past week
1.2M
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
High Financial Strength
77.8 / 100
Valuation Score
Mid Valuation
42.2 / 100
Momentum Score
Technically Moderately Bullish
65.4 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
71
1Yr Price target downside is -4%
9 analysts

31

S

3

W

2

O

1

T

SWOT Analysis

Halozyme Therapeutics Inc. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..